Carnet, Flora Perrin-Cocon, Laure Paillot, Romain Lotteau, Vincent Pronost, Stéphane Vidalain, Pierre-Olivier
Abstract Vaccination is one of the most widely used strategies to protect horses against pathogens. However, available equine vaccines often have limitations, as they do not always provide effective, long-term protection and booster injections are often required. In addition, research efforts are needed to develop effective vaccines against emergin...
Olivier, Timothée Haslam, Alyson Prasad, Vinay
BACKGROUND: The DYNAMIC trial investigated the use of circulating tumor DNA (ctDNA) to guide adjuvant treatment decisions in stage II colon cancer. Despite the DYNAMIC trials assertion that a ctDNA-guided approach could minimize the use of adjuvant treatment without compromising recurrence-free survival (RFS), we raised concerns regarding the trial...
Walia, Anushka Prasad, Vinay
The neoadjuvant and adjuvant use of immune checkpoint inhibitors (ICIs) in early stage non-small cell lung cancer (NSCLC) is increasing, with pembrolizumab approved as adjuvant therapy following surgical resection and chemotherapy by the U.S. Food and Drug Administration in early 2023. However, clinical trials of these agents have several key limit...
Stocker, Bridget L. Dangerfield, Emma M. Gupta, Sandeep K. Parlane, Natalie A. Foster, Amy J. Wedlock, D. Neil Timmer, Mattie S. M.
Published in
Pure and Applied Chemistry
Ovine pneumonia is a disease in sheep that is associated with major animal welfare issues and economic losses and for which there is no effective vaccine. We tested the adjuvanticity of our most promising α,α′-trehalose 6,6′-glycolipids, lipidated brartemicin adjuvants p-C18Brar (3), o-C18Brar (4), and amide-TDB (5) in vaccines for ovine pneumonia ...
Tsukidate, Taku Hang, Howard Griffin, Matthew
The characterization of microbiota mechanisms in health and disease has reinvigorated pattern recognition receptors as prominent targets for immunotherapy. Notably, our recent studies on Enterococcus species revealed peptidoglycan remodeling and activation of NOD2 as key mechanisms for microbiota enhancement of immune checkpoint inhibitor therapy. ...
Chang, Ryan Gulley, James L Fong, Lawrence
Immunotherapies, such as immune checkpoint inhibitors, cellular therapies, and T-cell engagers, have fundamentally changed our approach to treating cancer. However, successes with cancer vaccines have been more difficult to realize. While vaccines against specific viruses have been widely adopted to prevent the development of cancer, only two vacci...
Patel, Sapna Othus, Megan Chen, Yuanbin Wright, G Yost, Kathleen Hyngstrom, John Hu-Lieskovan, Siwen Lao, Christopher Fecher, Leslie Truong, Thach-Giao
...
BACKGROUND: Whether pembrolizumab given both before surgery (neoadjuvant therapy) and after surgery (adjuvant therapy), as compared with pembrolizumab given as adjuvant therapy alone, would increase event-free survival among patients with resectable stage III or IV melanoma is unknown. METHODS: In a phase 2 trial, we randomly assigned patients with...
Yin, Qian Luo, Wei Mallajosyula, Vamsee Bo, Yang Guo, Jing Xie, Jinghang Sun, Meng Verma, Rohit Li, Chunfeng Constantz, Christian M
...
The ideal vaccine against viruses such as influenza and SARS-CoV-2 must provide a robust, durable and broad immune protection against multiple viral variants. However, antibody responses to current vaccines often lack robust cross-reactivity. Here we describe a polymeric Toll-like receptor 7 agonist nanoparticle (TLR7-NP) adjuvant, which enhances l...
Goyal, Nishu Jerold, Frankline
Published in
Environmental science and pollution research international
The paper provides an overview of biocosmetics, which has tremendous potential for growth and is attracting huge business opportunities. It emphasizes the immediate need to replace conventional fossil-based ingredients in cosmetics with natural, safe, and effective ingredients. It assembles recent technologies viable in the production/extraction of...
Jan, Sharon Fratzke, Alycia Felgner, Jiin Hernandez-Davies, Jenny Nakajima, Rie Jasinskas, Algimantas Supnet, Medalyn Jain, Aarti Felgner, Philip Davies, D
...
Vaccines are among the most cost-effective public health measures for controlling infectious diseases. Coxiella burnetii is the etiological agent of Q fever, a disease with a wide clinical spectrum that ranges from mild symptoms, such as fever and fatigue, to more severe disease, such as pneumonia and endocarditis. The formalin-inactivated whole-ce...